CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Blinded independent validation of the PAM50-based Chemo-Endocrine Sensitivity Predictor (CESP) in hormone receptor (HR)-positive/HER2-negative (HR+/HER2-) breast cancer following neoadjuvant chemotherapy (NAC).
Author
Aleix Prat
Ana Isabel Lavado Fernandez
+18 more
Angela Santonja
Arthur Jeiranian
Begona Jimenez Rodriguez
Carl Schaper
Carlos Gonzalez-Hermoso
Cesar Ramirez Tortosa
Cristina Fernandez-Sousa
Elisabeth Perez Ruiz
Emilio Alba
Luis Vicioso
M Rosario Chica Parrado
Martina Alvarez
Naeem Dowidar
Nuria Ribelles
Pedro Sánchez Rovira
Sean Ferree
Vanessa de Luque
Wesley Buckingham
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Plasma sequencing of ctDNA in early stage breast cancer as part of the screening process.
Author
Alicia Garrido Aranda
Ana Lluch Hernandez
+18 more
Annette Nocon
Begona Bermejo
Begona Jimenez Rodriguez
Cristina Hernando
Daniel Mehnert
Emilio Alba
Estefania Bellagarza
Frank Holtrup
Frederick S. Jones
Gema Diaz Córdoba
Johannes Fredebohm
Luis Vicioso
M Rosario Chica Parrado
Mar Moreno Ros
Maria Jose Lozano
Martina Álvarez
Matthew B. Ryder
Vanessa de Luque
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref